TP63 and breast carcinoma: Immunohistochemistry using the antibodies p63, CK5 and p-cadherin, and also estrogen receptor (ER) and Human Epidermal Receptor Growth Factor 2 (HER2), was performed on 168 samples from a breast cancer case series.